Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Johnson-and-Johnson (JNJ) stocks
Learn how to easily invest in Johnson-and-Johnson stocks.
Johnson-and-Johnson is a drug manufacturers-general business based in the US. Johnson-and-Johnson stocks (JNJ.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $154.54 – an increase of 0.12% over the previous week. Johnson-and-Johnson employs 152,700 staff and has a trailing 12-month revenue of around $96.3 billion.
How to buy Johnson-and-Johnson stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – JNJ. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Johnson-and-Johnson?
- Has coronavirus impacted Johnson-and-Johnson shares?
- Johnson-and-Johnson shares summary
- Compare share dealing platforms
- Is Johnson-and-Johnson stock a buy or sell?
- Johnson-and-Johnson performance over time
- Is Johnson-and-Johnson suitable for ethical investing?
- Are Johnson-and-Johnson shares over-valued?
- Johnson-and-Johnson's financials
- How volatile are Johnson-and-Johnson shares?
- Does Johnson-and-Johnson pay a dividend?
- Have Johnson-and-Johnson shares ever split?
- Other common questions
Johnson-and-Johnson stock price (NYSE:JNJ)Use our graph to track the performance of JNJ stocks over time.
Johnson-and-Johnson shares at a glance
|Latest market close||$154.54|
|52-week range||$148.99 - $178.40|
|50-day moving average||$159.66|
|200-day moving average||$165.79|
|Wall St. target price||$179.45|
|Dividend yield||$4.52 (3.08%)|
|Earnings per share (TTM)||$4.77|
Buy Johnson-and-Johnson stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Johnson-and-Johnson stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Johnson-and-Johnson price performance over time
Historical closes compared with the close of $154.54 from 2023-06-01
|1 week (2023-05-26)||0.12%|
|1 month (2023-05-02)||-6.36%|
|3 months (2023-03-02)||1.37%|
|6 months (2022-12-02)||-13.61%|
|1 year (2022-06-01)||-13.04%|
|2 years (2021-05-29)||N/A|
|3 years (2020-06-02)||4.24%|
|5 years (2018-06-01)||27.45%|
Is Johnson-and-Johnson stock undervalued or overvalued?
Valuing Johnson-and-Johnson stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Johnson-and-Johnson's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Johnson-and-Johnson's P/E ratio
Johnson-and-Johnson's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 32x. In other words, Johnson-and-Johnson shares trade at around 32x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Johnson-and-Johnson's PEG ratio
Johnson-and-Johnson's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.7929. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Johnson-and-Johnson's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Johnson-and-Johnson's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $33.1 billion.
The EBITDA is a measure of a Johnson-and-Johnson's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$96.3 billion|
|Operating margin TTM||27.03%|
|Gross profit TTM||$64 billion|
|Return on assets TTM||8.69%|
|Return on equity TTM||17.48%|
|Market capitalisation||$401.3 billion|
TTM: trailing 12 months
Johnson-and-Johnson's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Johnson-and-Johnson.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Johnson-and-Johnson's total ESG risk score
Total ESG risk: 35.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Johnson-and-Johnson's overall score of 35.8 (as at 01/01/2019) is pretty weak – landing it in it in the 72nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Johnson-and-Johnson is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Johnson-and-Johnson's environmental score
Environmental score: 3.79/100
Johnson-and-Johnson's environmental score of 3.79 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Johnson-and-Johnson is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Johnson-and-Johnson's social score
Social score: 25.14/100
Johnson-and-Johnson's social score of 25.14 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Johnson-and-Johnson is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Johnson-and-Johnson's governance score
Governance score: 14.87/100
Johnson-and-Johnson's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Johnson-and-Johnson is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Johnson-and-Johnson's controversy score
Controversy score: 4/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Johnson-and-Johnson scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Johnson-and-Johnson has a damaged public profile.
Johnson-and-Johnson share dividends
Dividend payout ratio: 45.03% of net profits
Recently Johnson-and-Johnson has paid out, on average, around 45.03% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.08% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Johnson-and-Johnson shareholders could enjoy a 3.08% return on their shares, in the form of dividend payments. In Johnson-and-Johnson's case, that would currently equate to about $4.52 per share.
While Johnson-and-Johnson's payout ratio might seem fairly standard, it's worth remembering that Johnson-and-Johnson may be investing much of the rest of its net profits in future growth.
Johnson-and-Johnson's most recent dividend payout was on 6 June 2023. The latest dividend was paid out to all shareholders who bought their shares by 22 May 2023 (the "ex-dividend date").
Have Johnson-and-Johnson's shares ever split?
Johnson-and-Johnson's shares were split on a 2:1 basis on 13 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Johnson-and-Johnson shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Johnson-and-Johnson shares which in turn could have impacted Johnson-and-Johnson's share price.
Johnson-and-Johnson share price volatility
Over the last 12 months, Johnson-and-Johnson's shares have ranged in value from as little as $148.9859 up to $178.4011. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Johnson-and-Johnson's is 0.5345. This would suggest that Johnson-and-Johnson's shares are less volatile than average (for this exchange).
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o. b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors.
Stocks similar to Johnson-and-Johnson
Johnson-and-Johnson in the news
3 High-Quality Dividend Stocks Yielding 3% to Buy in June
UPDATE 1-J&J secures dismissal of whistleblower case over misuse of confidential info
J&J secures dismissal of whistleblower case over misuse of confidential info
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Best bad credit loans in PEI
Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
5 apps like Bree in Canada
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Debt Relief Canada (reliefcanada.ca) review
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Desjardins Online Brokerage (Disnat) review 2023
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
Guide to finding the best prepaid card in Canada in June 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.